Raphael Bosse, MD, PhD Joins Naples-Goodlette

News
Article

Raphael Bosse, MD, PhD has joined the Florida Cancer Specialists & Research Institute, LLC statewide practice.

Fort Myers, Fla., September 11, 2023 – Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to announce that Board-certified hematologist and medical oncologist Raphael Bosse, MD, PhD has joined the statewide practice. He is providing care to patients at the Naples-Goodlette location, 1100 Goodlette Road N., Naples, Florida 34102.

Dr. Bosse received his medical degree and doctorate in Molecular Cell Biology & Hematology from the University of Florida College of Medicine. Image Credit: © Florida Cancer Specialists & Research Institute, LLC

Dr. Bosse received his medical degree and doctorate in Molecular Cell Biology & Hematology from the University of Florida College of Medicine. Image Credit: © Florida Cancer Specialists & Research Institute, LLC

Dr. Bosse received his medical degree and doctorate in Molecular Cell Biology & Hematology from the University of Florida College of Medicine. He completed Internal Medicine residency training and a fellowship in Hematology and Oncology at the University of Florida Health Shands Hospitals in Gainesville.

FCS President & Managing Physician Lucio Gordan, MD said, “Dr. Bosse joins us with outstanding credentials. His extensive research experience is a great representation of his dedication to integrating the most advanced technologies and therapies to deliver personalized medicine to his patients.”

“We are delighted to welcome Dr. Bosse to our team of cancer experts in Collier County,” said FCS Chief Executive Officer Nathan H. Walcker. “He has received recognition for clinical excellence, and he is deeply committed to community outreach with demonstrated leadership in providing care to those who are underserved.”

Most recently, Dr. Bosse has led a quality program for Fellows aimed at facilitating serious illness conversations earlier in the treatment process. “His in-depth experience in steering clinical quality and documentation improvement initiatives aligns with the FCS holistic approach to providing value to patients,” continues Walcker.

Related Videos
A panel of 4 experts on breast cancer
A panel of 4 experts on breast cancer
A panel of 4 experts
A panel of 4 experts
Video 9 - "Unmet Needs in Relapsed or Refractory Multiple Myeloma"
Video 8 - "Bispecific Antibodies Versus CAR T-Cell Therapy for RRMM in the Community Oncology Setting"
Video 7 - "Role of Pharmacists in Operationalizing Bispecific Antibodies"
A panel of 4 experts
A panel of 4 experts
A panel of 3 experts on multiple myeloma
© 2024 MJH Life Sciences

All rights reserved.